For a current compounder or someone looking to enter the space, it is imperative that their business remains on top of the latest compounding developments.
Tera Lynn A. Rule, PharmD, JD, RPh, Esq
Advertisement
Articles by Tera Lynn A. Rule, PharmD, JD, RPh, Esq
Advertisement
Latest Updated Articles
Actions Following the FDA Compounding Priorities PlanPublished: January 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
5
